106 related articles for article (PubMed ID: 8172570)
1. C1q inhibitor (chondroitin-4-sulfate proteoglycan): structure and function.
Ghebrehiwet B; Galanakis DK
Behring Inst Mitt; 1993 Dec; (93):214-23. PubMed ID: 8172570
[TBL] [Abstract][Full Text] [Related]
2. Secreted chondroitin sulfate proteoglycan of human B cell lines binds to the complement protein C1q and inhibits complex formation of C1.
Kirschfink M; Blase L; Engelmann S; Schwartz-Albiez R
J Immunol; 1997 Feb; 158(3):1324-31. PubMed ID: 9013976
[TBL] [Abstract][Full Text] [Related]
3. The proteoglycan decorin binds C1q and inhibits the activity of the C1 complex.
Krumdieck R; Höök M; Rosenberg LC; Volanakis JE
J Immunol; 1992 Dec; 149(11):3695-701. PubMed ID: 1431141
[TBL] [Abstract][Full Text] [Related]
4. The receptor for the globular "heads" of C1q, gC1q-R, binds to fibrinogen/fibrin and impairs its polymerization.
Lu PD; Galanakis DK; Ghebrehiwet B; Peerschke EI
Clin Immunol; 1999 Mar; 90(3):360-7. PubMed ID: 10075865
[TBL] [Abstract][Full Text] [Related]
5. Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q.
Kilchherr E; Schumaker VN; Phillips ML; Curtiss LK
J Immunol; 1986 Jul; 137(1):255-62. PubMed ID: 3486914
[TBL] [Abstract][Full Text] [Related]
6. C1 subcomponent complexes: basic and clinical aspects.
Laurell AB; Sjöholm AG
Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the hemolytic activity of the first component of complement C1 by an Escherichia coli C1q binding protein.
van den Berg RH; Faber-Krol MC; van de Klundert JA; van Es LA; Daha MR
J Immunol; 1996 Jun; 156(11):4466-73. PubMed ID: 8666822
[TBL] [Abstract][Full Text] [Related]
8. A unique property of a plasma proteoglycan, the C1q inhibitor. An anticoagulant state resulting from its binding to fibrinogen.
Galanakis DK; Ghebrehiwet B
J Clin Invest; 1994 Jan; 93(1):303-10. PubMed ID: 8282801
[TBL] [Abstract][Full Text] [Related]
9. Complement C1q-target proteins recognition is inhibited by electric moment effectors.
Roumenina L; Bureeva S; Kantardjiev A; Karlinsky D; Andia-Pravdivy JE; Sim R; Kaplun A; Popov M; Kishore U; Atanasov B
J Mol Recognit; 2007; 20(5):405-15. PubMed ID: 17929239
[TBL] [Abstract][Full Text] [Related]
10. [Study of the relationship between complement activation and vascular endothelial damage in pregnancy induced hypertension].
Zheng Y; Chen Z; Yan J
Zhonghua Fu Chan Ke Za Zhi; 1996 Mar; 31(3):152-5. PubMed ID: 8758788
[TBL] [Abstract][Full Text] [Related]
11. Leukocyte-derived complement inhibitor. IV. The functional properties of C1 bound to erythrocytes pretreated with leukocyte culture supernatant.
Bernard A; Walter W; Teshima H; Boumsell L; Good RA; Day NK
J Immunol; 1976 Oct; 117(4):1117-26. PubMed ID: 977945
[TBL] [Abstract][Full Text] [Related]
12. Evidence that the two C1q binding membrane proteins, gC1q-R and cC1q-R, associate to form a complex.
Ghebrehiwet B; Lu PD; Zhang W; Keilbaugh SA; Leigh LE; Eggleton P; Reid KB; Peerschke EI
J Immunol; 1997 Aug; 159(3):1429-36. PubMed ID: 9233640
[TBL] [Abstract][Full Text] [Related]
13. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor.
Veerhuis R; Janssen I; De Groot CJ; Van Muiswinkel FL; Hack CE; Eikelenboom P
Exp Neurol; 1999 Nov; 160(1):289-99. PubMed ID: 10630213
[TBL] [Abstract][Full Text] [Related]
14. cC1q-R (calreticulin) and gC1q-R/p33: ubiquitously expressed multi-ligand binding cellular proteins involved in inflammation and infection.
Ghebrehiwet B; Peerschke EI
Mol Immunol; 2004 Jun; 41(2-3):173-83. PubMed ID: 15159063
[TBL] [Abstract][Full Text] [Related]
15. A small molecular weight factor in aqueous humor acts on C1q to prevent antibody-dependent complement activation.
Goslings WR; Prodeus AP; Streilein JW; Carroll MC; Jager MJ; Taylor AW
Invest Ophthalmol Vis Sci; 1998 May; 39(6):989-95. PubMed ID: 9579478
[TBL] [Abstract][Full Text] [Related]
16. Direct binding of C1q to apoptotic cells and cell blebs induces complement activation.
Nauta AJ; Trouw LA; Daha MR; Tijsma O; Nieuwland R; Schwaeble WJ; Gingras AR; Mantovani A; Hack EC; Roos A
Eur J Immunol; 2002 Jun; 32(6):1726-36. PubMed ID: 12115656
[TBL] [Abstract][Full Text] [Related]
17. beta-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain.
Jiang H; Burdick D; Glabe CG; Cotman CW; Tenner AJ
J Immunol; 1994 May; 152(10):5050-9. PubMed ID: 8176223
[TBL] [Abstract][Full Text] [Related]
18. Studies on the interactions between C-reactive protein and complement proteins.
Bíró A; Rovó Z; Papp D; Cervenak L; Varga L; Füst G; Thielens NM; Arlaud GJ; Prohászka Z
Immunology; 2007 May; 121(1):40-50. PubMed ID: 17244159
[TBL] [Abstract][Full Text] [Related]
19. Role of complement component C1q in the IgG-independent opsonophagocytosis of group B streptococcus.
Butko P; Nicholson-Weller A; Wessels MR
J Immunol; 1999 Sep; 163(5):2761-8. PubMed ID: 10453019
[TBL] [Abstract][Full Text] [Related]
20. C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion.
Tas SW; Klickstein LB; Barbashov SF; Nicholson-Weller A
J Immunol; 1999 Nov; 163(9):5056-63. PubMed ID: 10528211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
